Vectura Group Ltd

Pharmaceutical Analysis

With extensive, state-of-the-art analytical testing facilities and equipment, our expert teams are able to develop and validate the methodologies required to characterise inhaled delivery platforms, especially DPI, pMDI and nebulised products.

To ensure seamless support for your development, we also offer:

Comprehensive stability storage facilities able to support small bespoke stability studies through to large pivotal programmes.

Deep experience of development pharmaceutics, device verification testing and authoring of CMC sections for regulatory submissions.